Skip to main content
Search

# Toxicity Prediction

2 related articles

Subscribe to updates
  1. bioRxiv

    A Graph-based QSAR Modeling Pipeline for Predicting In vitro PubChem Assays and In vivo Human Hepatotoxicity: Mechanistic Analysis of Caspase-3/7 Activation

    This study developed a graph-based QSAR modeling pipeline integrating assay data preprocessing, fingerprint and molecular graph feature representations, and benchmarking of classical machine learning, graph neural networks, graph transformers, and their consensus ensembles, applied to predict Caspase-3/7 activation, mitochondrial membrane potential disruption, and FDA drug-induced liver injury, where Graphormer achieved the highest F1 of 0.79 and the full consensus model achieved the highest AUC of 0.69 on DILI prediction, surpassing the previous best model with AUC 0.63 and F1 0.65, and identified structural motifs associated with dual activation and cell-line-specific responses through fragment enrichment analysis.

  2. Artificial Intelligence in Toxicology: Current Advances, Challenges and Future Directions

    This review, based on a structured literature search of PubMed/MEDLINE, Web of Science and Scopus (2000-2026) supplemented by guidance documents from OECD, FDA, EMA, EFSA and EPA, traces the development of AI in toxicology from rule-based expert systems to deep learning, large language model and multimodal architectures, reports that graph neural networks and multi-task deep learning have shown competitive performance in selected benchmark studies of drug-induced liver injury, hERG cardiotoxicity and Ames mutagenicity, and concludes that inconsistent external validation, limited generalisation of endpoint-specific models and hallucination in large language models leave unresolved regulatory risks, so AI models augment but cannot yet replace experimental toxicology.

You’re all caught up